Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer

Yuchen Zhong1,2, Chaojing Zheng2, Weiyuan Zhang1,2

  • 1Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, Zhejiang, China.

Aging
|April 5, 2024
PubMed

Insights

Sushi domain-containing protein 4 (SUSD4) impacts cancer prognosis and immune response. Lower SUSD4 levels correlate with better outcomes, and targeting SUSD4 may offer new cancer therapies.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Sushi domain-containing protein 4 (SUSD4) is a complement regulatory protein involved in immune regulation.
  • The specific role of SUSD4 in cancer progression has been largely unclear.
  • This study investigates the association between SUSD4 and various cancer types.

Purpose of the Study:

  • To determine the prognostic value of SUSD4 in diverse cancers.
  • To explore the relationship between SUSD4 expression and the tumor microenvironment.
  • To investigate the functional role of SUSD4 in colorectal cancer and its potential as a therapeutic target.

Main Methods:

  • Bioinformatic analysis of SUSD4 expression across multiple cancer types.
  • Correlation analysis with immune cell infiltration, immune genes, tumor heterogeneity, and cancer pathways.
  • Functional validation in colorectal cancer cell lines, including SUSD4 knockdown.
  • Drug sensitivity assessment using organoid models.

Main Results:

  • SUSD4 expression levels are significantly associated with prognosis in multiple cancer types.
  • SUSD4 expression correlates with immune cell infiltration, immune-related genes, tumor heterogeneity, and cancer pathways.
  • Knockdown of SUSD4 inhibited colorectal cancer cell growth and affected the JAK/STAT pathway.
  • SUSD4 expression showed a positive correlation with the IC50 of Selumetinib, YK-4-279, and Piperlongumine.

Conclusions:

  • SUSD4 serves as a valuable prognostic biomarker for various cancers.
  • SUSD4 influences cancer progression through immune modulation and pathway involvement.
  • SUSD4 presents potential as a therapeutic target for cancer treatment.